Last reviewed · How we verify
NCT05261308
Customized Polyamide Prosthesis. for Mid Shaft Clavicle Fracture
NA trial testing new prosthesis in Treatment Adherence and Compliance in 1 participant. Completed in 18 April 2022.
14 August 2019
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1 |
| Start date | 16 March 2018 |
| Primary completion | 14 August 2019 |
| Estimated completion | 18 April 2022 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- new prosthesis
Conditions studied
- Treatment Adherence and Compliance — all drugs for Treatment Adherence and Compliance →
Sponsor
Cairo University
Who can join
Eligibility, male only, with Treatment Adherence and Compliance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Herein we describe the management of a patient who presented with progressive brachial plexopathy following the initial nonoperative management of a mid shaft clavicular fracture by using 3 D customized polyamide prosthesis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05261308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Treatment Adherence and Compliance
Currently open trials in the same condition.
- NCT06795243 — Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates. · NA · recruiting
- NCT06742827 — Educational Intervention and Adherence · NA · active not recruiting
- NCT06229171 — InTake Care: Development and Validation of an Innovative, Personalized Digital Health Solution for Medication Adherence · NA · recruiting
- NCT06354465 — Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews · recruiting
- NCT04656028 — Genetic Testing and Motivational Counseling for FH · NA · active not recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05261308 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 14 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05261308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing